Managing Complications of Chemotherapy Discussed on CME Webcast

OSUWexnerbloglogo2014 Managing Complications of Chemotherapy Discussed on CME Webcast. On this CME webcast, to update us is medical oncologist and Associate Professor of Internal Medicine from the Ohio State University and the James Cancer Hospital, Dr. Erin Bertino. And also from the James Cancer Hospital, Assistant Professor of Internal Medicine, Dr. Edmund Folefac.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the differences in toxicity for three categories of oncology therapy: cytotoxic chemotherapy, targeted therapy, and immunotherapy; and UNDERSTAND basic management of the most common toxicities of chemotherapy, targeted therapy, and immunotherapy.

You’ll also learn about the following:

  • Evolution of targeted therapies and immunotherapy
  • What to expect with cancer treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Therapies for Type 2 Diabetes

OSUWexnerbloglogo2014 Learn About New Therapies for Type 2 Diabetes. 25 years ago, the management of type II diabetes was easy. You started a patient on a sulfonylurea and then if their glucose level didn’t improve, you added in NPH insulin. But things have changed. And today, we have better and safer medications to treat diabetes. Which is a good thing because the prevalence of diabetes over the past 25 years has grown enormously and we really needed new treatments to fight against this public health threat. But with new treatments can come confusion about which to use in different clinical situations. Joining our moderator on this CME webcast, to update us on the management of type 2 diabetes is endocrinologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Joshua Joseph.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the role of new medical therapies in hypoglycemia; and DESCRIBE the role of new medical therapies in cardiovascular disease.

You’ll also learn about the following:

  • New directions in the treatment of type 2 diabetes
  • Hemoglobin A1C targets
  • Treatment of type 2 diabetes when medication cost is a consideration
  • New glucose monitoring technologies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses New Therapies for Lung Cancer

OSUWexnerbloglogo2014 CME Webcast Discusses New Therapies for Lung Cancer. On this CME webcast, we’re going to update you on the medical management of lung cancer and focus on non-small cell lung cancer. Joining our moderator in the studio is medical oncologist at the James Cancer Hospital and Professor of Internal Medicine from the Ohio State University, Dr. David Carbone.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review some of the latest practice-changing findings in the management of lung cancer; and Understand the basic principles of workup and initial lung cancer management decisions.

You’ll also learn about the following:

  • Classifying non-small cell lung cancer
  • Common side effects of driver-targeted therapies
  • What the primary care physician needs to know about co-managing patients taking driver-targeted therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

 

Learn about Breast Cancer Treatment on CME Webcast

OSUWexnerbloglogo2014 Learn About Breast Cancer Treatment on CME Webcast. Joining our moderator in the studio to tell us about many of the new treatments available to patients are two of Ohio State’s top experts in breast cancer. First, to tell us about the surgical management of breast cancer, we have surgical oncologist and Associate Professor of Surgery, Dr. Doreen Agnese. And then, to tell us about medications used in breast cancer, will be medical oncologist and Assistant Professor of Internal Medicine, Dr. Raquel Reinbolt.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW breast cancer systemic therapy approaches for early stage, locally advanced, and (briefly) metastatic breast cancer; REVIEW principles of survivorship; UNDERSTAND the current recommendations for screening and diagnosis of breast; and UNDERSTAND the surgical therapies for breast cancer and their consequences.

You’ll also learn about the following:

  • Surgical treatment options for breast cancer
  • New insights into breast cancer subtypes
  • Common side effects of treatment
  • The role of primary care in management of the breast cancer survivor

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Insomnia on On-line CME Webcast

OSUWexnerbloglogo2014 Learn about Insomnia on On-line CME Webcast. For many people, insomnia is a nightly occurrence, leading to nocturnal frustration and daytime fatigue. On this CME webcast, we’re going to explore insomnia, what causes it and what you can advise your patients to do about it. Our guests today are specialists in sleep medicine. Dr. Meena Khan is an Assistant Professor of Internal Medicine and of Neurology, and Dr. Jesse Mindel, who is an Assistant Professor of Neurology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW basic approaches to insomnia treatment; REVIEW available behavioral and pharmacologic therapies for insomnia; Describe the epidemiology and health implications of chronic insomnia; DESCRIBE the psychological characteristic of those with chronic insomnia; and DESCRIBE the behavioral and environmental factors that perpetuate chronic insomnia.

You’ll also learn about the following:

  • Common causes of insomnia
  • Normal sleep patterns
  • Melatonin
  • Sleep binging
  • Circadian rhythm disturbances
  • Eye patches and background noise recordings
  • Antihistamines
  • Approach to the patient who wakes up and cannot fall back to sleep
  • Approach to temporary situational insomnia

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.